Knowing that antibodies as well as viruses bind to certain proteins in certain ways, scientists have come up with a technique to watch both sickness-signaling materials stick to microscopic beads prepared for the purpose.
Doctors with Murayama Medical Center in Tokyo unveiled their device, which attaches to a normal pair of glasses, in the Journal of Neurosurgery: Spine.
His contributions to the specialty were numerous over the past 40-plus years, serving on 140 committees as a member of 15 different professional societies.
Rensselaer Polytechnic Institute and artificial intelligence firm Cleerly are also part of the collaboration seeking to improve care for those with heart disease.
The findings illustrate that even if such algorithms are ready for primetime, providers have work to do convincing patients of their efficacy, Dutch experts noted.